Benzodiazepine receptor binding was assessed in four Japanese men with
Machado-Joseph disease. Methods: The distribution of benzodiazepine r
eceptors was measured by radionuclide imaging (SPECT) after intravenou
s administration of I-123-iomazenil (Ro 16-0154), Results: SPECT demon
strated decreased binding throughout the cerebral cortex and cerebellu
m in all patients. Binding potential (receptor concentration x affinit
y) was diffusely decreased in cerebral cortex, thalamus, striatum and
cerebellum compared with control subjects, suggesting that GABAergic f
unction may be decreased globally in these patients. Cerebral blood fl
ow was largely normal, and no cerebral cortical atrophy was evident on
MRI, Conclusion: Iodine-123-iomazenil SPECT may become a potent metho
d for detecting impairment of the cerebral cortex even before brain pe
rfusion SPECT or MRI can reveal early abnormalities.